Jiang W, Long XM, Wei KQ, Li SC, Zhang Z, He BF, Li H. Application effect of thoracoscopic tricuspid valvuloplasty in geriatric patients with tricuspid valve disease. World J Clin Cases 2022; 10(15): 4810-4817 [PMID: 35801058 DOI: 10.12998/wjcc.v10.i15.4810]
Corresponding Author of This Article
Xiao-Mao Long, MD, Chief Physician, Department of Cardiothoracic and Vascular Surgery, The People’s Hospital of Guangxi Zhuang Autonomous Region, No. 6 Taoyuan Road, Qingxiu District, Nanning 530021, Guangxi Zhuang Autonomous Region, China. longluke369@163.com
Research Domain of This Article
Surgery
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. May 26, 2022; 10(15): 4810-4817 Published online May 26, 2022. doi: 10.12998/wjcc.v10.i15.4810
Application effect of thoracoscopic tricuspid valvuloplasty in geriatric patients with tricuspid valve disease
Wei Jiang, Xiao-Mao Long, Ke-Quan Wei, Si-Cong Li, Ze Zhang, Bang-Fu He, Hui Li
Wei Jiang, Xiao-Mao Long, Ke-Quan Wei, Si-Cong Li, Ze Zhang, Bang-Fu He, Hui Li, Department of Cardiothoracic and Vascular Surgery, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, Guangxi Zhuang Autonomous Region, China
Author contributions: Jiang W and Long XM designed this retrospective study; Jiang W wrote this manuscript; Jiang W, Long XM, Wei KQ, Li SC, Zhang Z, He BF and Lin H were responsible for sorting the data; and all authors have read and approve the final manuscript.
Supported byNatural Science Foundation of Guangxi Zhuang Autonomous Region of China, No. 2016GXNSFAA380079.
Institutional review board statement: The study was reviewed and approved by the Ethics Committee of the People’s Hospital of Guangxi Zhuang Autonomous Region. Institutional Review Board (Approval No. KY-LW-201802).
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: Nothing to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiao-Mao Long, MD, Chief Physician, Department of Cardiothoracic and Vascular Surgery, The People’s Hospital of Guangxi Zhuang Autonomous Region, No. 6 Taoyuan Road, Qingxiu District, Nanning 530021, Guangxi Zhuang Autonomous Region, China. longluke369@163.com
Received: January 10, 2022 Peer-review started: January 10, 2022 First decision: February 14, 2022 Revised: February 28, 2022 Accepted: March 26, 2022 Article in press: March 26, 2022 Published online: May 26, 2022 Processing time: 134 Days and 6.5 Hours
ARTICLE HIGHLIGHTS
Research background
The thoracoscopic assisted technique has the characteristics of small incision, clear surgical field and high safety.
Research motivation
This study investigated the effect of thoracoscopic tricuspid valvuloplasty in patients with tricuspid valve disease.
Research objectives
Whether thoracic assistive technology significantly reduced the duration of cardiopulmonary bypass, aorta blocking time, endotracheal intubation time, operation time, postoperative C-reactive protein, white blood cell count, cardiac troponin T, creatine kinase isoenzyme, creatine kinase and the incidence of adverse events between the two groups and traditional surgery.
Research methods
A total of 41 patients with tricuspid valve disease underwent traditional thoracotomy treatment were included. Patients in the study group underwent thoracoscopic tricuspid valvuloplasty and were intubated with a 35 F double-lumen endotracheal tube for one-lung ventilation. Patients in the control group underwent a traditional thoracotomy. From the medical records, we collected information on operational conditions, including the duration of extracorporeal circulation, aorta blocking, endotracheal intubation, and surgery.
Research results
The duration of extracorporeal circulation, aortic occlusion, endotracheal intubation, and hospital stay was shorter in the study group than in the control group. The incidence of adverse events in the study group was significantly lower than that in the control group.
Research conclusions
Thoracoscopic tricuspid valvuloplasty can achieve good results in treating patients with tricuspid valve disease, reduce the risk of adverse events, and promote the rapid recovery of patients.
Research perspectives
We will expand the scope of the clinical study and increase the sample size to further explore and confirm whether the results of the study have a wide range of effectiveness.
